PAVI-TAVI Registry Overview
The PAVI-TAVI Registry is an observational study at Fondazione IRCCS Policlinico San Matteo in Pavia, Italy. It tracks real-world outcomes of transcatheter heart valve procedures like TAVI (for aortic stenosis), valve-in-valve (VIV), TAVI for aortic insufficiency (TAVI-IAo), and TMVR (for degenerated mitral valves) in patients over 18 years old.
Who Can Join Eligible patients include adults treated with these procedures on native aortic valves, failed aortic bioprostheses, or degenerated mitral prostheses/rings. The only exclusion is not providing informed consent.
Study Goals The main goal is to evaluate TAVI's safety and effectiveness over 5 years, focusing on all-cause mortality from the initial procedure. Secondary goals assess complication rates, valve function, inflammation markers, heart failure hospitalizations, heart attacks, strokes, and major cardiac events.
How It Works No experimental treatments-it's a registry collecting routine clinical data via a secure electronic system. Follow-up happens at your doctor's discretion, ideally at 3 and 12 months, then yearly (often by phone for stable cases). The study aims to enroll 500+ patients.
Age > 18 years.
Transcatheter treatment with a bioprosthesis on native aortic valve, on degenerated aortic bioprosthesis, or on degenerated mitral prostheses/rings.
Failure to sign the informed consent.
All patients treated with TAVI, VIV, TAVI-IAo, and TMVR at Fondazione IRCCS Policlinico San Matteo will be eligible for enrollment.
Cohort
Other
Not applicable, as this is a registry tracking all TAVI procedures performed at IRCCS Policlinico San Matteo
DeviceNot applicable, as this is a registry tracking all TAVI procedures performed at IRCCS Policlinico San Matteo
5-years all cause death
All-cause mortality at 5-year follow-up from the index procedure
Number of in-hospital adverse events (VARC-2 criteria)
Number of in-hospital adverse events (VARC-2 criteria)
Number of patients with bioprosthetic valve dysfunction
Number of patients with bioprosthetic valve dysfunction
Assessment of pre- and post-procedural inflammatory indices (neutrophil-to-lymphocyte ratio and uric acid), if available, in TAVI-treated patients and correlation with clinical outcomes and prosthesis degeneration (SVD).
HF Hospitalization rate
HF Hospitalization rate
Click on the lead sponsor to view all of their trials.
